Tubulysin drug‐linkers 1 and 2 were conjugated to an anti‐CD30 antibody as DAR 2 and mixed DAR 4 ADCs and evaluated for cytotoxicity against a panel of CD30+ lymphoma cell lines (Table 1). Here, TNFRSF8 is linked to lymphoma.